Attached files
file | filename |
---|---|
10-Q - FORM 10-Q - RESEARCH PHARMACEUTICAL SERVICES, INC. | c92451e10vq.htm |
EX-10.1 - EXHIBIT 10.1 - RESEARCH PHARMACEUTICAL SERVICES, INC. | c92451exv10w1.htm |
EX-31.1 - EXHIBIT 31.1 - RESEARCH PHARMACEUTICAL SERVICES, INC. | c92451exv31w1.htm |
EX-32.2 - EXHIBIT 32.2 - RESEARCH PHARMACEUTICAL SERVICES, INC. | c92451exv32w2.htm |
EX-31.2 - EXHIBIT 31.2 - RESEARCH PHARMACEUTICAL SERVICES, INC. | c92451exv31w2.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of ReSearch Pharmaceutical Services,
Inc. (the Company) for the three months ended September 30, 2009, as filed with the Securities
and Exchange Commission on the date hereof (the Report), I, Daniel M. Perlman, certify, pursuant
to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002,
that to the best of my knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company. |
Dated: November 13, 2009
/s/ Daniel M. Perlman |
||
Chief Executive Officer |